DaVitaMEX:DVA 80 FCF Yield % is 10.72 as of Jun. 29, 2026, which is 1% below its 10-year median of 10.83. GuruFocus rates MEX:DVA with a GF Score™ of 80/100 and a GF Value™ of MXN2,689.69 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 683 Healthcare Providers & Services companies, DaVita ranks better than 83.89% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, DaVita's Trailing 12-Month Free Cash Flow is MXN27,377 Mil, and Market Cap is MXN244,043 Mil. Therefore, DaVita's FCF Yield % for today is 10.72%.
The historical rank and industry rank for DaVita's FCF Yield % or its related term are showing as below:
MEX:DVA'
s FCF Yield % Range Over the Past 10 Years
Min: 3.65 Med: 10.83 Max: 19.1
Current: 10.72
During the past 13 years, the highest FCF Yield % of DaVita was 19.10%. The lowest was 3.65%. And the median was 10.83%.
MEX:DVA's FCF Yield % is ranked better than 83.89% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.88
vs MEX:DVA: 10.72
DaVita's FCF Margin % for the quarter that ended in Mar. 2026 was 6.41%.
DaVita FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
DaVita FCF Yield % Related Terms
DaVita FCF Yield % Historical Data
* Premium members only.
The historical data trend for DaVita's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, DaVita's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's FCF Yield % distribution charts can be found below:
* The bar in red indicates where DaVita's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaVita (MEX:DVA) has a FCF Yield % of 10.72 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DaVita and its competitors. This is near median its historical median of 10.83. Over the past decade, DaVita's FCF Yield % has ranged from 3.65 to 19.10. According to the industry distribution chart, DaVita ranks #110 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 16.1%.
Is DaVita's FCF Yield % too high?
DaVita's current FCF Yield % of 10.72 is near median its 10-year median of 10.83. Over the past 10 years, this metric has ranged from a low of 3.65 to a high of 19.10. The Healthcare Providers & Services industry median FCF Yield % is 1.88. DaVita's value of 10.72 is 470.2% above this industry median. Based on the distribution chart, DaVita ranks #110 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DaVita has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's FCF Yield % compare to THC and EHC?
According to the Healthcare Providers & Services industry distribution chart, DaVita ranks #110 out of 683 companies for FCF Yield %. This places DaVita in the top 16% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.88. DaVita's value of 10.72 is 470.2% above this benchmark. Historically, DaVita's own FCF Yield % has ranged from 3.65 to 19.10 over the past decade. While the company's 10-year median is 10.83 vs. the industry median of 1.88, DaVita has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.88, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DaVita's current FCF Yield % of 10.72 is 470.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DaVita and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DaVita's current FCF Yield % is 10.72, which is near median its own 10-year median of 10.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (MEX:DVA) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN2,689.69, compared to a current price of MXN3,358.09 — trading 24.9% above its estimated fair value. The current FCF Yield % is 10.72, which is near median its 10-year median of 10.83 and 470.2% above the Healthcare Providers & Services industry median of 1.88. DaVita's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For DaVita (MEX:DVA), the current FCF Yield % is 10.72 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaVita (MEX:DVA) Overvalued in 2026?
Based on GuruFocus' analysis, DaVita stock appears to be overvalued.
The current stock price of MXN3,358.09 is trading 24.9% above its estimated GF Value™ of MXN2,689.69.
GuruFocus considers DaVita to be Modestly Overvalued.
Key valuation signals for MEX:DVA:
FCF Yield %: 10.72 (near median its 10-year median of 10.83)
GF Value™: MXN2,689.69 vs. price of MXN3,358.09 (24.9% above fair value)
Industry Position: 470.2% above the Healthcare Providers & Services median (#110 of 683)
No single metric tells the full story. See the MEX:DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
80GF Score
Get the complete analysis for MEX:DVA
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:DVA has been successfully added to your 
